01 2025 CAS Annual Conference
The Chinese Antibody Society (CAS) is a global professional organization focused on therapeutic antibodies. It is committed to creating a platform that fosters collaboration and communication in the fields of therapeutic antibody discovery, development, manufacturing, and commercialization. In 2025, antibody drugs, as a core area of modern biopharmaceuticals, are undergoing breakthroughs across multiple dimensions. From precisely targeted antibody-drug conjugates (ADCs) to emerging antibody-oligonucleotide conjugates (AOCs), from radioligand conjugates (RDCs) to bispecific antibodies (BsAbs), technological innovations and clinical translation are rapidly advancing, reshaping treatment landscapes in oncology, autoimmune diseases, and rare diseases.
In light of these new breakthroughs and the rapid development of antibody therapeutics—alongside the opportunities and challenges that arise—the CAS 2025 Annual Meeting will be held on Saturday, May 10, 2025, in Cambridge, Massachusetts, under the theme “New Frontiers of Bispecific Antibodies, Antibody Drug Conjugates and Beyond.”
As a sponsor of this event, DIMA BIOTECH is proud to support the global advancement of antibody therapeutics. Dr. Donghui Ma, CEO of DIMA BIOTECH, will deliver a keynote presentation titled “Therapeutic mAb Discovery for Multi-pass Transmembrane Protein Targets” at 3:50 p.m. on May 10, 2025.
We warmly welcome our partners and industry colleagues to visit us at Booth #1 to discuss collaboration opportunities!
02 21STAnnual PEGS BOSTON
The PEGS (Essential Protein & Antibody Engineering Summit) is a premier global event in the field of biotherapeutics, covering all aspects of biologic drug development and offering in-depth discussions on protein and antibody engineering, immunotherapy, expression platforms, immunogenicity, and more. Each year, PEGS attracts biotech and biopharma professionals from around the world to this knowledge-rich summit.
Building upon its legacy of excellence, the 2025 PEGS Boston Summit will continue to serve as a flagship event in the field of biotherapeutics and protein engineering. It will bring together global experts, innovators, and industry leaders to share cutting-edge insights into drug development, protein and antibody engineering, immunotherapy, radiotherapy, and AI/ML-driven biologics research. This year’s summit features over 300 presentations, panel discussions, and interactive workshops, providing attendees with unparalleled opportunities to learn from top-tier experts from the pharmaceutical, biotech, academic, and government sectors.
At this event, DIMA BIOTECH will present a poster showcasing our lead molecule discovery solutions targeting multi-pass transmembrane protein targets. We also welcome you to visit us at Booth #820 to engage in conversations with our team!
